10Nov, 2026

Wexecutive Breakfast series | Global Pharma Strategy and US pricing | 10th of November

Summary

Global Pharma Strategy and US pricing | 10th of November

Speaker

W Executive

Guest Speakers

Marco Lucchin

Marco Lucchin

Consultant, Wexecutive

Bruno Parenti

Bruno Parenti

Recordati Rare Diseases, Managing Director, Head of LATAM, APAC & CIS Region

Stefano De Socio Lardani

Stefano De Socio Lardani

Cambridge Judge Business School - Recordati

About this event

The evolving US pharmaceutical pricing landscape is increasingly shaping global strategic decisions—from portfolio prioritization and launch sequencing to investment allocation and geographic expansion.

This event will explore how changes in US pricing dynamics may influence global pharma strategies, with a particular focus on the opportunities and challenges of expanding into emerging markets. Through industry perspectives it will be discussed how companies can adapt their commercial and geographic strategies in an increasingly complex and interconnected environment.

The event is co-organized by the University of Cambridge Alumni Interest Support Group for Health & Biotech, bringing together members of the Cambridge alumni community and industry leaders for an engaging exchange of perspectives and experiences.


A W Executive Breakfast series event

The event is organized by W Executive in collaboration with the Univeristy of Cambridge - Judge Business School Alumni Special Interest Group Health & Biotech. The event is run according to the Chatham House Rule and is kindly hosted by our partner Signature.

Stefano De Socio Lardani will be the moderator for this event. 


Agenda

8.30: doors open

9.00-9.30: panel

9.30-9.45 Q&A

9.45 onwards: networking


Partner


Sponsor

Stay up to date with upcoming events, insights, and sessions.

 View our events hub 


Consult with Our Experts